These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25257573)

  • 1. Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.
    Anderson JL; Fromentin R; Corbelli GM; Østergaard L; Ross AL
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):36-44. PubMed ID: 25257573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reservoirs dog AIDS therapy.
    Smaglik P
    Nature; 2000 May; 405(6784):270-2. PubMed ID: 10830936
    [No Abstract]   [Full Text] [Related]  

  • 3. Forcing the enemy to come out and surrender: a strategy for an AIDS cure.
    Al-Jabri AA
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):45-6. PubMed ID: 25456568
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/AIDS: waiting for a cure.
    Shearer WT
    J Allergy Clin Immunol; 2008 Jul; 122(1):34-5. PubMed ID: 18547632
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
    Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
    Siliciano JD; Siliciano RF
    J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.
    Cohn LB; Chomont N; Deeks SG
    Cell Host Microbe; 2020 Apr; 27(4):519-530. PubMed ID: 32272077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities.
    Rausch JW; Le Grice SFJ
    Curr HIV Res; 2020; 18(2):99-113. PubMed ID: 31889490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate vaccines for immunotherapy in HIV.
    Gotch FM; Imami N; Hardy G
    HIV Med; 2001 Oct; 2(4):260-5. PubMed ID: 11737407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
    Shan L; Siliciano RF
    Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why cure, why now?
    Kuritzkes DR
    J Med Ethics; 2017 Feb; 43(2):67-70. PubMed ID: 27273887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IAS Towards an HIV Cure Symposium: people focused, science driven: 18-19 July 2015, Vancouver, Canada.
    Fidler S; Thornhill J; Malatinkova E; Reinhard R; Lamplough R; Ananworanich J; Chahroudi A
    J Virus Erad; 2015 Oct; 1(4):276-81. PubMed ID: 27482425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards an HIV cure: a global scientific strategy.
    ; Deeks SG; Autran B; Berkhout B; Benkirane M; Cairns S; Chomont N; Chun TW; Churchill M; Di Mascio M; Katlama C; Lafeuillade A; Landay A; Lederman M; Lewin SR; Maldarelli F; Margolis D; Markowitz M; Martinez-Picado J; Mullins JI; Mellors J; Moreno S; O'Doherty U; Palmer S; Penicaud MC; Peterlin M; Poli G; Routy JP; Rouzioux C; Silvestri G; Stevenson M; Telenti A; Van Lint C; Verdin E; Woolfrey A; Zaia J; Barré-Sinoussi F
    Nat Rev Immunol; 2012 Jul; 12(8):607-14. PubMed ID: 22814509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.
    Lu P; Qu X; Shen Y; Jiang Z; Wang P; Zeng H; Ji H; Deng J; Yang X; Li X; Lu H; Zhu H
    Sci Rep; 2016 Apr; 6():24100. PubMed ID: 27067814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
    Bobardt M; Kuo J; Chatterji U; Chanda S; Little SJ; Wiedemann N; Vuagniaux G; Gallay PA
    PLoS One; 2019; 14(2):e0211746. PubMed ID: 30716099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.